New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis

被引:25
作者
Guerrero, R
Martin, MAD
Diego, EMD
Disla, T
Rapado, A
delaPiedra, C
机构
[1] FDN JIMENEZ DIAZ,SERV BIOQUIM CLIN,LAB METAB MINERAL & OSEO,E-28040 MADRID,SPAIN
[2] FDN JIMENEZ DIAZ,MED INTERNA SERV,E-28040 MADRID,SPAIN
关键词
bone resorption markers; CTX; hydroxyproline; ICTP; postmenopausal osteoporosis; pyridinoline;
D O I
10.1007/BF01623388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this work was to perform a comparative study between three recently developed biochemical markers of bone resorption derived from collagen metabolism - (1) total urinary free pyridinolines (Pyr), (2) serum pyridinoline cross-linked carboxyterminal telopeptides of type I collagen (ICTP) and (3) a urinary-specific sequence for a part of the C-telopeptide of the alpha(1) chain of type I collagen (CTX) - in the diagnosis and follow-up of postmenopausal osteoporosis. Results were also evaluated relative to the classical biochemical marker urinary hydroxyproline (Hyp). The study included 20 untreated osteoporotic postmenopausal women (OSP), age 60 +/- 6 years, range 46-69 years; 27 osteoporotic postmenopausal women treated (OSP-T) by cyclic therapy with disodium etidronate, 25-hydroxyvitamin D and calcium for a period between 3 months and 4 years (25 +/- 15 months), age 59 +/- 7 years, range 41-67 years; 17 osteopenic postmenopausal women, age 57 +/- 6 years, range 46 +/- 68 years; and 29 healthy control postmenopausal women, age 56 +/- 7 years, range 41-70 years. The diagnostic criterion for postmenopausal osteoporosis was a bone mineral density (BMD) (Hologic QDR-1000) in lumbar spine and/or femoral neck more than 2 SD below the mean value corresponding to an age- and sex-matched healthy control group. For inclusion in the osteopenic group BMD values had to be between 1 and 2 SD below the mean BMD value corresponding to the control group. We found a significant increase (p<0.01) in the levels of Pyr/Cr and CTX/Cr (Cr = creatinine) in OSP patients with respect to the control group and we did not obeserve any significant difference between control and OSP-T or osteopenic women. It is interesting to note that there was a mean increase in CTX/Cr in OSP patients of 101% of the control values, while the mean increase found in Pyr/Cr concentration was only 33%. However, we did not find significant differences in the concentrations of ICTP and Hyp/Cr between groups. In a comparison of Pyr/Cr and CTX/Cr, urinary CTX showed the higher diagnostic accuracy, as can be deduced from the receiver operating characteristic (ROC) curves. CTX sensitivity was 40% with a specificity of 100%, whereas the sensitivity was 25% for urinary Pyr/Cr. In conclusion, the results of the present work suggest that in osteoporotic women CTX has the highest diagnostic accuracy among the markers of bone resporption studied.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 28 条
[1]   APPLICATIONS OF AN ENZYME-IMMUNOASSAY FOR A NEW MARKER OF BONE-RESORPTION (CROSSLAPS) - FOLLOW-UP ON HORMONE REPLACEMENT THERAPY AND OSTEOPOROSIS RISK ASSESSMENT [J].
BONDE, M ;
QVIST, P ;
FLEDELIUS, C ;
RIIS, BJ ;
CHRISTIANSEN, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :864-868
[2]  
BONDE M, 1994, CLIN CHEM, V40, P2024
[3]   ASSESSMENT OF BONE REMODELING USING BIOCHEMICAL INDICATORS OF TYPE-I COLLAGEN-SYNTHESIS AND DEGRADATION - RELATION TO CALCIUM KINETICS [J].
CHARLES, P ;
MOSEKILDE, L ;
RISTELI, L ;
RISTELI, J ;
ERIKSEN, EF .
BONE AND MINERAL, 1994, 24 (02) :81-94
[4]  
DELMAS PD, 1993, J BONE MINER RES, V8, pS549
[5]   EVALUATION OF BONE TURNOVER IN TYPE-I OSTEOPOROSIS USING BIOCHEMICAL MARKERS SPECIFIC FOR BOTH BONE-FORMATION AND BONE-RESORPTION [J].
EASTELL, R ;
ROBINS, SP ;
COLWELL, T ;
ASSIRI, AMA ;
RIGGS, BL ;
RUSSELL, RGG .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 (05) :255-260
[6]  
EYRE DR, 1992, J CLIN ENDOCR METAB, V74, P470
[7]   THE DIAGNOSTIC VALIDITY OF URINARY FREE PYRIDINOLINES TO IDENTIFY WOMEN AT RISK OF OSTEOPOROSIS [J].
FLEDELIUS, C ;
RIIS, BJ ;
OVERGAARD, K ;
CHRISTIANSEN, C .
CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (05) :381-384
[8]   COMPARISON OF NEW BIOCHEMICAL MARKERS OF BONE TURNOVER IN LATE POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN RESPONSE TO ALENDRONATE TREATMENT [J].
GARNERO, P ;
SHIH, WCJ ;
GINEYTS, E ;
KARPF, DB ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1693-1700
[9]  
GARNERO P, 1995, J BONE MINER RES, V10, P641
[10]   ASSESSMENT OF BONE-RESORPTION WITH A NEW MARKER OF COLLAGEN DEGRADATION IN PATIENTS WITH METABOLIC BONE-DISEASE [J].
GARNERO, P ;
GINEYTS, E ;
RIOU, JP ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) :780-785